A citation-based method for searching scientific literature

Kirsi M Kinnunen, Adam J Schwarz, Emily C Turner, Dorian Pustina, Emily C Gantman, Mark F Gordon, Richard Joules, Ariana P Mullin, Rachael I Scahill, Nellie Georgiou-Karistianis. Front Neurol 2021
Times Cited: 6







List of co-cited articles
22 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Rachael I Scahill, Paul Zeun, Katherine Osborne-Crowley, Eileanoir B Johnson, Sarah Gregory, Christopher Parker, Jessica Lowe, Akshay Nair, Claire O'Callaghan, Christelle Langley,[...]. Lancet Neurol 2020
54
66



Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
505
50

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
33

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
659
33

Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease.
Ariana P Mullin, Diane Corey, Emily C Turner, Richard Liwski, Daniel Olson, Jackson Burton, Sudhir Sivakumaran, Lynn D Hudson, Klaus Romero, Diane T Stephenson,[...]. Clin Transl Sci 2021
2
100

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.
Sarah J Tabrizi, Michael D Flower, Christopher A Ross, Edward J Wild. Nat Rev Neurol 2020
72
33

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
541
33

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
139
33

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Lauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, Peter A Wijeratne, Enrico De Vita, Daniel C Alexander, Giuseppe Palermo, Christian Czech, Scott Schobel, Rachael I Scahill,[...]. Sci Transl Med 2018
66
33

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
560
33

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
172
33

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
Maria Björkqvist, Edward J Wild, Jenny Thiele, Aurelio Silvestroni, Ralph Andre, Nayana Lahiri, Elsa Raibon, Richard V Lee, Caroline L Benn, Denis Soulet,[...]. J Exp Med 2008
391
33

Fluid and imaging biomarkers for Huntington's disease.
Paul Zeun, Rachael I Scahill, Sarah J Tabrizi, Edward J Wild. Mol Cell Neurosci 2019
18
33

An image-based model of brain volume biomarker changes in Huntington's disease.
Peter A Wijeratne, Alexandra L Young, Neil P Oxtoby, Razvan V Marinescu, Nicholas C Firth, Eileanoir B Johnson, Amrita Mohan, Cristina Sampaio, Rachael I Scahill, Sarah J Tabrizi,[...]. Ann Clin Transl Neurol 2018
26
33

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
629
33

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
146
33

Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials.
Kirsi M Kinnunen, Ariana P Mullin, Dorian Pustina, Emily C Turner, Jackson Burton, Mark F Gordon, Rachael I Scahill, Emily C Gantman, Simon Noble, Klaus Romero,[...]. Front Neurol 2021
2
100

HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
Julie C Stout, Sarah Queller, Kalyca N Baker, Sean Cowlishaw, Cristina Sampaio, Cheryl Fitzer-Attas, Beth Borowsky. Mov Disord 2014
53
33


Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
552
33

Effective Data Sharing as a Conduit for Advancing Medical Product Development.
Stephen R Karpen, J Kael White, Ariana P Mullin, Inish O'Doherty, Lynn D Hudson, Klaus Romero, Sudhir Sivakumaran, Diane Stephenson, Emily C Turner, Jane Larkindale. Ther Innov Regul Sci 2021
4
25

Prospective motion correction with volumetric navigators (vNavs) reduces the bias and variance in brain morphometry induced by subject motion.
M Dylan Tisdall, Martin Reuter, Abid Qureshi, Randy L Buckner, Bruce Fischl, André J W van der Kouwe. Neuroimage 2016
65
16

Identification of Anonymous MRI Research Participants with Face-Recognition Software.
Christopher G Schwarz, Walter K Kremers, Terry M Therneau, Richard R Sharp, Jeffrey L Gunter, Prashanthi Vemuri, Arvin Arani, Anthony J Spychalla, Kejal Kantarci, David S Knopman,[...]. N Engl J Med 2019
47
16

Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement.
Kelvin K Leung, Ian M Malone, Sebastien Ourselin, Jeffrey L Gunter, Matt A Bernstein, Paul M Thompson, Clifford R Jack, Michael W Weiner, Nick C Fox. Neuroimage 2015
15
16

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.
Clifford R Jack, Frederik Barkhof, Matt A Bernstein, Marc Cantillon, Patricia E Cole, Charles Decarli, Bruno Dubois, Simon Duchesne, Nick C Fox, Giovanni B Frisoni,[...]. Alzheimers Dement 2011
136
16

Multisite neuroimaging trials.
John Darrell Van Horn, Arthur W Toga. Curr Opin Neurol 2009
56
16


Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance.
Marina Boccardi, Martina Bocchetta, Liana G Apostolova, Josephine Barnes, George Bartzokis, Gabriele Corbetta, Charles DeCarli, Leyla deToledo-Morrell, Michael Firbank, Rossana Ganzola,[...]. Alzheimers Dement 2015
91
16

Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Enchi Liu, Johan Luthman, Jesse M Cedarbaum, Mark E Schmidt, Patricia E Cole, James Hendrix, Maria C Carrillo, Dorothy Jones-Davis, Erika Tarver, Gerald Novak,[...]. Alzheimers Dement 2015
8
16

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Dallas P Veitch, Michael W Weiner, Paul S Aisen, Laurel A Beckett, Nigel J Cairns, Robert C Green, Danielle Harvey, Clifford R Jack, William Jagust, John C Morris,[...]. Alzheimers Dement 2019
135
16

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
Michael W Weiner, Dallas P Veitch, Paul S Aisen, Laurel A Beckett, Nigel J Cairns, Jesse Cedarbaum, Michael C Donohue, Robert C Green, Danielle Harvey, Clifford R Jack,[...]. Alzheimers Dement 2015
120
16

A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
Emily N Manning, Kelvin K Leung, Jennifer M Nicholas, Ian B Malone, M Jorge Cardoso, Jonathan M Schott, Nick C Fox, Josephine Barnes. Neuroinformatics 2017
9
16

Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project.
Simon Duchesne, Fernando Valdivia, Nicolas Robitaille, Abderazzak Mouiha, F Abiel Valdivia, Martina Bocchetta, Liana G Apostolova, Rossana Ganzola, Greg Preboske, Dominik Wolf,[...]. Alzheimers Dement 2015
15
16

Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment.
David L Raunig, Lisa M McShane, Gene Pennello, Constantine Gatsonis, Paul L Carson, James T Voyvodic, Richard L Wahl, Brenda F Kurland, Adam J Schwarz, Mithat Gönen,[...]. Stat Methods Med Res 2015
191
16

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.
Giovanni B Frisoni, Clifford R Jack, Martina Bocchetta, Corinna Bauer, Kristian S Frederiksen, Yawu Liu, Gregory Preboske, Tim Swihart, Melanie Blair, Enrica Cavedo,[...]. Alzheimers Dement 2015
127
16

MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.
Xue Hua, Christopher R K Ching, Adam Mezher, Boris A Gutman, Derrek P Hibar, Priya Bhatt, Alex D Leow, Clifford R Jack, Matt A Bernstein, Michael W Weiner,[...]. Neurobiol Aging 2016
31
16

Structural imaging in premanifest and manifest Huntington disease.
Rachael I Scahill, Ralph Andre, Sarah J Tabrizi, Elizabeth H Aylward. Handb Clin Neurol 2017
14
16

Dopamine and Huntington's disease.
Laetitia C Schwab, Shady N Garas, Janelle Drouin-Ouellet, Sarah L Mason, Simon R Stott, Roger A Barker. Expert Rev Neurother 2015
35
16

Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.
Stephen Marder, W Wolfgang Fleischhacker, Willie Earley, Kaifeng Lu, Yan Zhong, György Németh, István Laszlovszky, Erzsébet Szalai, Suresh Durgam. Eur Neuropsychopharmacol 2019
23
16

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.
Virginie Czernecki, Michael Schüpbach, Sadek Yaici, Richard Lévy, Eric Bardinet, Jérôme Yelnik, Bruno Dubois, Yves Agid. Mov Disord 2008
140
16


Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Ying Li, Shan Hai, Yan Zhou, Bi Rong Dong. Cochrane Database Syst Rev 2015
37
16

Motivation, reward, and Parkinson's disease: influence of dopatherapy.
V Czernecki, B Pillon, J L Houeto, J B Pochon, R Levy, B Dubois. Neuropsychologia 2002
257
16

D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells.
Rebecca L Clarkson, Alayna T Liptak, Steven M Gee, Vikaas S Sohal, Kevin J Bender. J Neurosci 2017
49
16



Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease.
Sandra Franco-Iborra, Ainhoa Plaza-Zabala, Marta Montpeyo, David Sebastian, Miquel Vila, Marta Martinez-Vicente. Autophagy 2021
50
16

Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.
Béla Kiss, István Laszlovszky, Balázs Krámos, András Visegrády, Amrita Bobok, György Lévay, Balázs Lendvai, Viktor Román. Biomolecules 2021
13
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.